Style | Citing Format |
---|---|
MLA | Namdari M, Eatemadi A. "Cardioprotective Effects of Curcumin-Loaded Magnetic Hydrogel Nanocomposite (Nanocurcumin) Against Doxorubicin-Induced Cardiac Toxicity in Rat Cardiomyocyte Cell Lines." Artificial Cells# Nanomedicine and Biotechnology, vol. 45, no. 4, 2017, pp. 731-739. |
APA | Namdari M, Eatemadi A (2017). Cardioprotective Effects of Curcumin-Loaded Magnetic Hydrogel Nanocomposite (Nanocurcumin) Against Doxorubicin-Induced Cardiac Toxicity in Rat Cardiomyocyte Cell Lines. Artificial Cells# Nanomedicine and Biotechnology, 45(4), 731-739. |
Chicago | Namdari M, Eatemadi A. "Cardioprotective Effects of Curcumin-Loaded Magnetic Hydrogel Nanocomposite (Nanocurcumin) Against Doxorubicin-Induced Cardiac Toxicity in Rat Cardiomyocyte Cell Lines." Artificial Cells# Nanomedicine and Biotechnology 45, no. 4 (2017): 731-739. |
Harvard | Namdari M, Eatemadi A (2017) 'Cardioprotective Effects of Curcumin-Loaded Magnetic Hydrogel Nanocomposite (Nanocurcumin) Against Doxorubicin-Induced Cardiac Toxicity in Rat Cardiomyocyte Cell Lines', Artificial Cells# Nanomedicine and Biotechnology, 45(4), pp. 731-739. |
Vancouver | Namdari M, Eatemadi A. Cardioprotective Effects of Curcumin-Loaded Magnetic Hydrogel Nanocomposite (Nanocurcumin) Against Doxorubicin-Induced Cardiac Toxicity in Rat Cardiomyocyte Cell Lines. Artificial Cells# Nanomedicine and Biotechnology. 2017;45(4):731-739. |
BibTex | @article{ author = {Namdari M and Eatemadi A}, title = {Cardioprotective Effects of Curcumin-Loaded Magnetic Hydrogel Nanocomposite (Nanocurcumin) Against Doxorubicin-Induced Cardiac Toxicity in Rat Cardiomyocyte Cell Lines}, journal = {Artificial Cells# Nanomedicine and Biotechnology}, volume = {45}, number = {4}, pages = {731-739}, year = {2017} } |
RIS | TY - JOUR AU - Namdari M AU - Eatemadi A TI - Cardioprotective Effects of Curcumin-Loaded Magnetic Hydrogel Nanocomposite (Nanocurcumin) Against Doxorubicin-Induced Cardiac Toxicity in Rat Cardiomyocyte Cell Lines JO - Artificial Cells# Nanomedicine and Biotechnology VL - 45 IS - 4 SP - 731 EP - 739 PY - 2017 ER - |